| Target | KDM3B |
|---|
| Product Type | Antibody |
|---|
| Application | IHC (P), WB |
|---|
| Clonality | Polyclonal |
|---|
| Conjugate | unconjugated |
|---|
| Isotype | IgG |
|---|
| Immunogen | Recombinant fusion protein containing a sequence corresponding to amino acids 400-600 of human KDM3B (NP_057688.2). |
|---|
| Host Species | Rabbit |
|---|
| Species Reactivity | Human |
|---|
| Formulation | PBS with 0.09% Sodium azide,50% glycerol |
|---|
| Research Area | CancerEpigenetics |
|---|
| Description/Background | This protein is predicted to enable chromatin DNA binding activity; histone H3-methyl-lysine-9 demethylase activity; and transcription coregulator activity. predicted to be involved in histone H3-K9 demethylation and regulation of transcription by RNA polymerase II. located in nucleoplasm. Biomarker of acute lymphoblastic leukemia; breast cancer; colorectal cancer; and lung non-small cell carcinoma. |
|---|
| Storage Temperature | Store at -20℃ |
|---|
| Protocols | IHC (P), WB |
|---|
| Molecular Weight | 192kDa |
|---|
| Purification | Affinity purification |
|---|
| Regulatory Statement | For Research Use Only. Not for use in diagnostic procedures. |
|---|
